期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Discussions on real-world acupuncture treatments for chroni clow-back pain in older adults 被引量:8
1
作者 Arthur Yin Fan Hui Ouyang +7 位作者 Xinru Qian Hui Wei David Dehui Wang Deguang He Haihe Tian Changzhen Gong Amy Matecki Sarah Faggert Alemi 《Journal of Integrative Medicine》 SCIE CAS CSCD 2019年第2期71-76,共6页
Chronic low-back pain(CLBP) is one of the most common pain conditions. Current clinical guidelines for low-back pain recommend acupuncture for CLBP. However, there are very few high-quality acupuncture studies on CLBP... Chronic low-back pain(CLBP) is one of the most common pain conditions. Current clinical guidelines for low-back pain recommend acupuncture for CLBP. However, there are very few high-quality acupuncture studies on CLBP in older adults. Clinical acupuncture experts in the American Traditional Chinese Medicine Association(ATCMA) were interested in the recent grant on CLBP research announced by the National Center for Complementary and Integrative Health. The ATCMA experts held an online discussion on the subject of real-world acupuncture treatments for CLBP in older adults. Seven participants, each with more than 20 years of acupuncture practice, discussed their own unique clinical experience while another participant talked about the potential mechanism of acupuncture in pain management. As a result of the discussion, a picture of a similar treatment strategy emerged across the participants for CLBP in older adults. This discussion shows that acupuncture may have complicated mechanisms in pain management, yet it is effective for the treatment of chronic pain involving maladaptive neuroplasticity;therefore, it should be effective for CLBP in older adults. 展开更多
关键词 Acupuncture PRAGMATIC clinical trials as TOPIC Real world Treatment strategies LOW-BACK PAIN OLDER ADULTS Discussion
原文传递
Recovery of a patient with severe COVID-19 by acupuncture and Chinese herbal medicine adjuvant to standard care 被引量:4
2
作者 Xin Yin Shu-bin Cai +5 位作者 Lan-ting Tao Lu-ming Chen Zhong-de Zhang Su-hong Xiao Arthur Yin Fan Xu Zou 《Journal of Integrative Medicine》 SCIE CAS CSCD 2021年第5期460-466,共7页
There is currently no drug or therapy that can cure the coronavirus disease 2019(COVID-19), which is highly contagious and can be life-threatening in severe cases. Therefore, seeking potential effective therapies is a... There is currently no drug or therapy that can cure the coronavirus disease 2019(COVID-19), which is highly contagious and can be life-threatening in severe cases. Therefore, seeking potential effective therapies is an urgent task. An older female at the Leishenshan Hospital in Wuhan, China, with a severe case of COVID-19 with significant shortness of breath and decrease in peripheral oxygen saturation(SpO_(2)),was treated using manual acupuncture and Chinese herbal medicine granule formula Fuzheng Rescue Lung with Xuebijing Injection in addition to standard care. The patient’s breath rate, SpO_(2), heart rate,ratio of neutrophil/lymphocyte(NLR), ratio of monocyte/lymphocyte(MLR), C-reactive protein(CRP),and chest computed tomography were monitored. Acupuncture significantly improved the patient’s breathing function, increased SpO_(2), and decreased her heart rate. Chinese herbal medicine might make the effect of acupuncture more stable;the use of herbal medicine also seemed to accelerate the absorption of lung infection lesions when its dosage was increased. The combination of acupuncture and herbs decreased NLR from 14.14 to 5.83, MLR from 1.15 to 0.33 and CRP from 15.25 to 6.01 mg/L. These results indicate that acupuncture and Chinese herbal medicine, as adjuvants to standard care, might achieve better results in treating severe cases of COVID-19. 展开更多
关键词 COVID-19 Severe case Case report ACUPUNCTURE Chinese herbal medicine Integrative therapy
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部